| Biological, clinical, and ethical advances of placebo effects DG Finniss, TJ Kaptchuk, F Miller, F Benedetti The Lancet 375 (9715), 686-695, 2010 | 1460 | 2010 |
| Placebos without deception: a randomized controlled trial in irritable bowel syndrome TJ Kaptchuk, E Friedlander, JM Kelley, MN Sanchez, E Kokkotou, ... PloS one 5 (12), e15591, 2010 | 1183 | 2010 |
| Placebo effects in medicine TJ Kaptchuk, FG Miller N Engl J Med 373 (1), 8-9, 2015 | 558 | 2015 |
| A critique of clinical equipoise: therapeutic misconception in the ethics of clinical trials FG Miller, H Brody Hastings Center Report 33 (3), 19-28, 2003 | 549 | 2003 |
| The nocebo effect and its relevance for clinical practice L Colloca, FG Miller Psychosomatic medicine 73 (7), 598-603, 2011 | 515 | 2011 |
| Clinical trials and medical care: defining the therapeutic misconception GE Henderson, LR Churchill, AM Davis, MM Easter, C Grady, S Joffe, ... PLoS medicine 4 (11), e324, 2007 | 504 | 2007 |
| The Oxford textbook of clinical research ethics EJ Emanuel, CC Grady, RA Crouch, RK Lie, FG Miller, DD Wendler Oxford University Press, 2008 | 452 | 2008 |
| The ethics of placebo-controlled trials—a middle ground EJ Emanuel, FG Miller New England Journal of Medicine 345 (12), 915-919, 2001 | 436 | 2001 |
| How placebo responses are formed: a learning perspective L Colloca, FG Miller Philosophical Transactions of the Royal Society B: Biological Sciences 366 …, 2011 | 418 | 2011 |
| Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists JC Tilburt, EJ Emanuel, TJ Kaptchuk, FA Curlin, FG Miller Bmj 337, 2008 | 366 | 2008 |
| The power of context: reconceptualizing the placebo effect FG Miller, TJ Kaptchuk Journal of the Royal Society of Medicine 101 (5), 222-225, 2008 | 320 | 2008 |
| The placebo effect: illness and interpersonal healing FG Miller, L Colloca, TJ Kaptchuk Perspectives in biology and medicine 52 (4), 518-539, 2009 | 319 | 2009 |
| Disclosing individual results of clinical research: implications of respect for participants DI Shalowitz, FG Miller Jama 294 (6), 737-740, 2005 | 310 | 2005 |
| The therapeutic orientation to clinical trials FG Miller, DL Rosenstein New England Journal of Medicine 348 (14), 1383-1386, 2003 | 303 | 2003 |
| The dead donor rule and organ transplantation RD Truog, FG Miller N Engl J Med 359 (7), 674-675, 2008 | 299 | 2008 |
| What makes placebo-controlled trials unethical? FG Miller, H Brody The American Journal of Bioethics 2 (2), 3-9, 2002 | 284 | 2002 |
| Communicating the results of clinical research to participants: attitudes, practices, and future directions DI Shalowitz, FG Miller PLoS medicine 5 (5), e91, 2008 | 265 | 2008 |
| Effects of placebos without deception compared with no treatment: a systematic review and meta‐analysis JEG Charlesworth, G Petkovic, JM Kelley, M Hunter, I Onakpoya, ... Journal of Evidence‐Based Medicine 10 (2), 97-107, 2017 | 238 | 2017 |
| Ethical issues in community-based participatory research: balancing rigorous research with community participation in community intervention studies DR Buchanan, FG Miller, N Wallerstein Progress in community health partnerships: research, education, and action 1 …, 2007 | 219 | 2007 |
| Professional integrity in clinical research FG Miller, DL Rosenstein, EG DeRenzo Jama 280 (16), 1449-1454, 1998 | 218 | 1998 |
